Free Trial

KDA Group (CVE:KDA) Shares Down 3.8%

→ Financial Stranglehold on the U.S. (From Porter & Company) (Ad)
KDA Group logo with Medical background

Shares of KDA Group Inc. (CVE:KDA - Get Free Report) dropped 3.8% during mid-day trading on Wednesday . The company traded as low as C$0.38 and last traded at C$0.38. Approximately 13,790 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 98,375 shares. The stock had previously closed at C$0.40.

KDA Group Stock Down 3.8 %

The company has a market cap of C$66.58 million, a P/E ratio of -7.50 and a beta of 1.07. The company has a quick ratio of 0.35, a current ratio of 2.71 and a debt-to-equity ratio of 15.64. The company has a fifty day moving average of C$0.43 and a 200 day moving average of C$0.31.

Insider Buying and Selling at KDA Group

In other KDA Group news, Director Marc Lemieux acquired 88,000 shares of the company's stock in a transaction that occurred on Wednesday, February 28th. The shares were bought at an average price of C$0.43 per share, with a total value of C$37,840.00. In related news, Director Marc Lemieux bought 88,000 shares of the firm's stock in a transaction that occurred on Wednesday, February 28th. The shares were bought at an average cost of C$0.43 per share, with a total value of C$37,840.00. Also, Director Isabelle Bégin bought 101,500 shares of the stock in a transaction that occurred on Monday, February 26th. The shares were bought at an average price of C$0.42 per share, for a total transaction of C$42,630.00. Corporate insiders own 25.53% of the company's stock.

KDA Group Company Profile

(Get Free Report)

KDA Group Inc, together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in KDA Group right now?

Before you consider KDA Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KDA Group wasn't on the list.

While KDA Group currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Will FOMC Push Stocks Higher? Here’s What to Expect
Unlock Growth: Understanding Dividend Yield
Palantir Stock Excluded from S&P 500: Still a Buy?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines